BioHarvest Issues Shareholder Letter and Provides Corporate Update
Vancouver, British Columbia and Rehovot, Israel – January 8, 2025– BioHarvest Sciences Inc., (Nasdaq: BHST) (CSE: BHSC) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholders, 2024 can be summarized as a year […]
BioHarvest Issues Shareholder Letter and Provides Corporate Update Read More »